Search research articles
Contact Us
Filters
Showing results (371-380 of 454) with videos related to
Page
of 46
Sort By:
The Journal of Clinical Investigation
|
May 16, 2012
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
Venkata Lokesh Battula, Yuexi Shi, Kurt W Evans, et al.
The American Journal of Dermatopathology
|
December 8, 2020
Male Mammary Paget Disease: A Tale of 2 Contrasting Cases
Madhuchhanda Roy, Mediget Teshome, Senthilkumar Damodaran, et al.
Scientific Reports
|
November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer
Uyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
British Journal of Cancer
|
January 13, 2017
Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
Takeo Fujii, Takahiro Kogawa, Jimin Wu, et al.
Cancer Journal (Sudbury, Mass.)
|
December 26, 2002
Global gene expression changes during neoadjuvant chemotherapy for human breast cancer
Thomas A Buchholz, David N Stivers, James Stec, et al.
Archives of Pathology & Laboratory Medicine
|
October 21, 2022
Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting
Gábor Cserni, Edi Brogi, Hiram S Cody, et al.
Annals of Surgical Oncology
|
August 1, 2012
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns
Abigail S Caudle, Kelly K Hunt, Susan L Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor Approach
Taiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Cancer
|
March 5, 2005
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry
Anees Chagpar, Lavinia P Middleton, Aysegul A Sahin, et al.
Cancer Cell
|
August 25, 2004
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Yoichi Nagata, Keng-Hsueh Lan, Xiaoyan Zhou, et al.
Page
of 46
Search research articles
Search
Showing results (371-380 of 454) with videos related to
Sort By:
Page
of 46
The Journal of Clinical Investigation
|
May 16, 2012
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
Venkata Lokesh Battula, Yuexi Shi, Kurt W Evans, et al.
The American Journal of Dermatopathology
|
December 8, 2020
Male Mammary Paget Disease: A Tale of 2 Contrasting Cases
Madhuchhanda Roy, Mediget Teshome, Senthilkumar Damodaran, et al.
Scientific Reports
|
November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer
Uyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
British Journal of Cancer
|
January 13, 2017
Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
Takeo Fujii, Takahiro Kogawa, Jimin Wu, et al.
Cancer Journal (Sudbury, Mass.)
|
December 26, 2002
Global gene expression changes during neoadjuvant chemotherapy for human breast cancer
Thomas A Buchholz, David N Stivers, James Stec, et al.
Archives of Pathology & Laboratory Medicine
|
October 21, 2022
Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting
Gábor Cserni, Edi Brogi, Hiram S Cody, et al.
Annals of Surgical Oncology
|
August 1, 2012
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns
Abigail S Caudle, Kelly K Hunt, Susan L Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor Approach
Taiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Cancer
|
March 5, 2005
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry
Anees Chagpar, Lavinia P Middleton, Aysegul A Sahin, et al.
Cancer Cell
|
August 25, 2004
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Yoichi Nagata, Keng-Hsueh Lan, Xiaoyan Zhou, et al.
Page
of 46